Generated: December 16, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022369
« Back to Dashboard
, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the LATISSE profile page.
The generic ingredient in LATISSE is bimatoprost. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.
Summary for 022369
|Therapeutic Class:||Ophthalmic Agents|
Medical Subject Heading (MeSH) Categories for 022369
Suppliers and Packaging for NDA: 022369
||National Drug Code
||1 BOTTLE, DROPPER in 1 CARTON (0023-3616-04) > 3 mL in 1 BOTTLE, DROPPER
||1 BOTTLE, DROPPER in 1 CARTON (0023-3616-03) > 3 mL in 1 BOTTLE, DROPPER
|Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Dec 24, 2008||TE:||AT||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Sep 4, 2017
|Regulatory Exclusivity Use:||INFORMATION ADDED TO THE PEDIATRIC USE SECTION OF THE LABELING REGARDING USE OF LATISSE IN PATIENTS WHO WERE POST-CHEMOTHERAPY OR HAD ALOPECIA AREATA, AND ADOLESCENTS WHO HAD HYPERTRICHOSIS WITH NO ASSOCIATED MEDICAL CONDITION|
|Patent:||► Subscribe||Patent Expiration:||Aug 25, 2023||Product Flag?||Y||Substance Flag?||Y||Delist Request?|
|Patented Use:||TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS|
|Patent:||► Subscribe||Patent Expiration:||May 25, 2024||Product Flag?||Substance Flag?||Delist Request?|
|Patented Use:||METHOD OF INCREASING HAIR GROWTH|
Expired Orange Book Patents for NDA: 022369
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.